| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.003 |